glp-1 als agonists linked to faster progression of some neurological diseases GLP-1-related antihyperglycemic medication use is

Additionally, dehydration secondary to vomiting or reduced oral intake due to nausea may result in a dry, scratchy throat

Given that glutamine metabolism increases the amount of GSH in cells by maintaining the NADPH/NADP + ratio and by preventing export and extracellular degradation of GSSG, glutamine is the primary amino acid that controls cellular GSH homeostasis

Who GLP-1 weight loss is for - and who it isn't Patients we typically work with on GLP-1 weight management: Adults with BMI 30+ (obesity) who have not achieved sustained weight loss with lifestyle change alone Adults with BMI 27+ and weight-related comorbidities - type 2 diabetes, hypertension, dyslipidemia, sleep apnea, prediabetes, fatty liver disease Patients with insulin resistance or metabolic syndrome where the metabolic and weight pictures are intertwined Patients post-bariatric surgery with weight regain, where appropriate and coordinated with their surgical team GLP-1 medications are not appropriate for patients with personal or family history of medullary thyroid carcinoma, MEN2 syndrome, history of pancreatitis, severe gastroparesis, or active eating disorders

Corbetta S, Vicentini L, Ferrero S, Lania A, Mantovani G, Cordella D, et al